The role of nootropic supplements is becoming increasingly relevant in today's integrated therapeutic landscape. 1 The choice of adjunctive therapy is increasingly complex because of the increasingly elaborate nature of the drugs and, consequently, the potentially resulting drug interactions. The use of a nootropic, although it has an active component, turns out to be less disruptive overall because of the fewer interactions resulting from its very nature; another aspect not to be underestimated is the general propensity of the patient to take a product to which he or she does not attribute the exact nature as the drug generally used in therapy, and this allows the clinician to be able to administer an effective add-on with good compliance on the part of the patient. 2 Among nootropic supplements, Nosustrophine has an important role. The effects of this supplement are manifold, and currently, its use is found in the treatment of Alzheimer's disease (AD). Among pharmacological interventions, the most widely used in AD are natural products (25.6%), followed by anti-amyloid beta